Gilead Sciences Inc (NASDAQ: GILD)
DRUGS - Biotechnology
Health Care
Stock price data as of
Closing price: $122.81
-
Support level$118.31
-
Resistance levelN/A
-
Beta0.3
-
RSI (14-day)77.0
- GILD is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- Volatility is forecast to fall over the next month.
- With RSI > 70, GILD is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $86.29 | $122.81 | 100.0% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $108.34 | $115.35 | $114.99 | $117.82 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week6.2%
-
In the next month13.4%
-
In the next year52.8%
| Period | Value |
|---|---|
| Historical (5 year) | 23.3% |
| Last month | 23.5% |
| Current estimate | 22.9% |
| Next month forecast | 23.6% |